This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over. It aims to improve the quality of life for adults with multiple sclerosis by promoting symptom management, comprehensive reviews and effective relapse treatment.

The guideline does not cover disease-modifying treatments. These are covered by the technology appraisals on the multiple sclerosis page of the NICE website.

Recommendations

This guideline includes recommendations on:

Who is it for?

  • Healthcare professionals
  • Social care practitioners
  • Commissioners and providers
  • Adults with multiple sclerosis and their families and carers

Guideline development process

How we develop NICE guidelines

This guideline updates and replaces NICE guideline CG8 (November 2003).

Next review: October 2018

This guideline was previously called multiple sclerosis: management of multiple sclerosis in primary and secondary care.

Your responsibility

The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or service users. The application of the recommendations in this guideline is not mandatory and the guideline does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.

Local commissioners and/or providers have a responsibility to enable the guideline to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with compliance with those duties.

Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.

  • National Institute for Health and Care Excellence (NICE)